Corneal correction for presbyopes

Article

Ner and intermediate vision improvement with a corneal impant

"For a corneal correction of presbyopia to provide a broad depth of focus is exciting news for refractive surgery," according to Dr Vance Thompson, Sioux Falls, South Dakota, USA, speaking of his experiences using the KAMRA inlay (AcuFocus, Irvine, California, USA) at this year's meeting of the American Society of Cataract and Refractive Surgeons (ASCRS). During the same session several doctors revealed their findings using the KAMRA inlay, including an analysis of task performance after implantation, improvements to near vision in emmetropic presbyopic patients, as well as results of simultaneous implantation of the inlay with LASIK.

Quality of life

Dr Thompson examined the task performance of his patients post-implantation. He enrolled 44 patients out of the current IDE total of 507 patients. The patients were between 45 and 60 years of age and ranged from +0.5 to –0.75 D. Dr Thompson said, "In our group of patients their near vision started out blurry but postimplantation there was an improvement to, on average, J2."

Dr Thompson also examined the patients' quality of life after 18 months post-op. He said, "We asked the patients how easy it is for them to perform various everyday tasks at far, intermediate and near distances." Preoperatively, all patients had difficulty reading or viewing a computer screen without glasses, but Dr Thompson said the KAMRA inlay changed that. "After implantation you can see a nice improvement in the intermediate range, looking at the computer screen. You go a little nearer and ask the patients to view a newspaper or a menu and you see a dramatic improvement. Everything is much easier after the implant, even driving at night patients felt comfortable," he added.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.